Molecular Modelling Approaches to the Design of Acetylcholinesterase Inhibitors: New Challenges for the Treatment of Alzheimer's Disease

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|10|25|3131-3140

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.10, Iss.25, 2004-01, pp. : 3131-3140

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Acetylcholinesterase inhibitors in the treatment of Alzheimer’s disease

By Gauthier S.  

Expert Opinion on Investigational Drugs, Vol. 8, Iss. 10, 1999-10 ,pp. : 1511-1520

Informa Healthcare

Access to resources Recommend Favorite

Acetylcholinesterase inhibitors for the treatment of dementia in Alzheimer’s disease: do we need new inhibitors?

By Small David H  

Expert Opinion on Emerging Drugs, Vol. 10, Iss. 4, 2005-11 ,pp. : 817-825

Informa Healthcare

Access to resources Recommend Favorite

Tacrine-Huperzine A Hybrids (Huprines) A New Class of Highly Potent and Selective Acetylcholinesterase Inhibitors of Interest for the Treatment of Alzheimer Disease

By  

Mini Reviews in Medicinal Chemistry, Vol. 1, Iss. 2, 2001-07 ,pp. : 163-174

Bentham Science Publishers

Access to resources Recommend Favorite

From Traditional European Medicine to Discovery of New Drug Candidates for the Treatment of Dementia and Alzheimer's Disease: Acetylcholinesterase Inhibitors

By  

Current Medicinal Chemistry, Vol. 20, Iss. 8, 2013-03 ,pp. : 976-983

Bentham Science Publishers

Access to resources Recommend Favorite

Discovery of Anti-Alzheimer Agents: Current Ligand-Based Approaches toward the Design of Acetylcholinesterase Inhibitors

By  

Mini Reviews in Medicinal Chemistry, Vol. 12, Iss. 6, 2012-06 ,pp. : 583-591

Bentham Science Publishers

Access to resources Recommend Favorite